• EMCORE

  • 著者: Peter Kas
  • ポッドキャスト

EMCORE

著者: Peter Kas
  • サマリー

  • Remember how it felt when you saw that really difficult patient and knew exactly what to do? What if you had the knowledge to do that with all of your patients? What would that look like? What would it sound like? How would you feel? We take care of people. They come to us because they need our expertise. The EM SHOW is about the latest evidence and deconstructing the performance of the best clinical specialists, to bring you knowledge that can take you to the level of 'Outstanding'. "The Knowledge you take into Your Shift, DOES Matter".

    Copyright 2024 Peter Kas
    続きを読む 一部表示

あらすじ・解説

Remember how it felt when you saw that really difficult patient and knew exactly what to do? What if you had the knowledge to do that with all of your patients? What would that look like? What would it sound like? How would you feel? We take care of people. They come to us because they need our expertise. The EM SHOW is about the latest evidence and deconstructing the performance of the best clinical specialists, to bring you knowledge that can take you to the level of 'Outstanding'. "The Knowledge you take into Your Shift, DOES Matter".

Copyright 2024 Peter Kas
エピソード
  • Episode 13: Diplopia
    2024/07/24

    A patient walks into the Emergency Department with a complaint of Diplopia. "I'm seeing Double".
    How do you approach this situation?
    What are the causes?
    How do we tell the difference between Monocular and Binocular?
    Here are 5 things I do.

    続きを読む 一部表示
    9 分
  • Episode 12: Guillain Barre Syndrome
    2024/02/23

    This is a low frequency High stakes Disease we cannot miss.

    続きを読む 一部表示
    12 分
  • Episode 11: Do steroids decrease mortality in severe community acquired pneumonia
    2024/02/15

    Here is a controversial paper with mortality findings very different to what has been published before.
    The Community-Acquired Pneumonia: Evaluation of Corticosteroids (CAPE COD) Trial, was a double-blind, randomised, controlled, superiority trial, conducted in 31 French ICUs.
    Intravenous hydrocortisone, 200mg, was given within 24 hours of onset of severity criteria (median time < 15 hours). The results were very different to the previous study conducted in 42 ICU centres.

    続きを読む 一部表示
    8 分
activate_buybox_copy_target_t1

EMCOREに寄せられたリスナーの声

カスタマーレビュー:以下のタブを選択することで、他のサイトのレビューをご覧になれます。